AzTrials
AzTrials

StrokePROWALKNCT06327035

Evolution of Walking Abilities in Subacute Stroke Patients Hospitalized in Neurorehabilitation Center

An observational study of Stroke and Gait, Hemiplegic, run by Clinique Les Trois Soleils at 3 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this observational study is to describe the evolution of gait recovery during the subacute phase of stroke up to six months after stroke, in patients hospitalized in medical and neurological rehabilitation units. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Stroke, Gait, Hemiplegic
What is being tested?
Gait rehabilitation
How many people
400 participants
Where
3 sitesFrance
Study dates
26 Mar 2024to 1 Apr 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke patient hospitalized in one of the investigating centers during acute/subacute phase.

Who may be able to join

  • Patient hospitalized in one of the investigating centers after acute/subacute stroke.
  • Affiliated to a social security scheme

Who cannot join

  • Opposed to its participation in this study
  • Neurodegenerative disease impacting gait prior to stroke onset
  • Patient not walking before stroke
  • Progressive pathology with life-threatening consequences within 6 months
  • Patient under legal protection

Trial locations and contacts

3 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Anne-Gaëlle Grosmaire contact

+33164717372

ag.grosmaire@les-trois-soleils.fr

Ophélie Pila, Phd contact

o.pila@les-trois-soleils.fr

France3 sites, 3 recruiting
  • Clinique Les Trois Soleils

    Boissise-le-Roi, 77310

    Christophe Duret, MD, ch.duret@les-trois-soleils.fr

    Christophe Duret, MD

    Recruiting
  • La Clinique Les Trois Soleils

    Boissise-le-Roi, 77310

    Ophélie Pila, PhD

    Christophe Duret, MD

    Recruiting
  • Le Normandy

    Granville, Normandy, 50400

    Anne Peskine, MD, +33233903333, apeskine.normandy@lna-sante.com

    Soizic Injeyan, PT, +33233903333, dirmissions.normandy@lna-sante.com

    Recruiting

Other trials in France

About this study

Official title: Neurological Recovery of the Paretic Lower Limb and Balance and Walking Abilities in the Subacute Phase of Stroke in Patients Hospitalized in Medical and Rehabilitation Units: A Prospective Multicenter Longitudinal Study

The goal of this observational study is to describe the evolution of gait recovery during the subacute phase of stroke up to six months after stroke, in patients hospitalized in medical and neurological rehabilitation units.

Being tested
Gait rehabilitation
Keywords
stroke, lower limb, gait recovery, balance
Medical subject headings
Stroke, Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Gait rehabilitationOther

    Assessment of gait and balance abilities after stroke during neurorehabilitation from the subacute phase of stroke to 6 months after stroke.

    The assessments will be carried out on entrance to the neurological center, then at 1 ,3 and 6 months and on hospital discharge.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Ambulation Classification

    The Functional Ambulation Categories (FAC) is a 6-point functional walking test that evaluates ambulation ability.

    Measured: Functional Ambulation Classification will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

Secondary outcomes (5)
  1. Postural Assesment Scale for Stroke Patient

    The Postural Assessment Scale for Stroke Patients (PASS) assesses balance in lying, sitting and standing positions. It was designed specifically for patients with stroke and is suitable for all individuals regardless of postural performance.

    The PASS consists of a 4-point scale where items are scored from 0 - 3. The total score ranges from 0 - 36, the higher the score is, the more favourable the balance in stroke patients.

    Measured: Postural Assesment Scale for Stroke Patient will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

  2. Timed Up and Go

    The Timed Up and Go is a general physical performance test used to assess mobility, balance and locomotor performance. More specifically, it assesses the ability to perform sequential motor tasks relative to walking and turning.

    Measured: Timed Up and Go will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

  3. 10-Meter Walk Test

    The 10 Metre Walk Test is a performance measure used to assess walking speed in meters per second over a short distance

    Measured: 10-Meter Walk Test will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

  4. 6Minute-Walk Test

    The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.

    Measured: 6Minute-Walk Test will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

  5. Motricity Index

    The Motricity Index (MI) is an ordinal method of measuring limb strength. The total score ranges from 0 - 100, with the higher numbers representing good muscle strength.

    Measured: Motricity Index will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Mar 2024
  2. Study start26 Mar 2024
  3. Primary completion1 Mar 2027 (estimated)
  4. Study completion1 Apr 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
400 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06327035
Sponsor's protocol ID
2023-A02660-45
Acronym
PROWALK
Status last verified
Mar 2026
First submitted
15 Mar 2024
Last updated
17 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke and Gait, Hemiplegic, run by Clinique Les Trois Soleils at 3 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 17 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Anne-Gaëlle Grosmaire (+33164717372, ag.grosmaire@les-trois-soleils.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Ambulation Classification (time frame: Functional Ambulation Classification will be carried out within 72 hours of admission to the neurological center, then at 1, 3 and 6 months, and at discharge from hospital (assessed up to 5 days).). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in